EFTR Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

SPRZEDAż 108981 min ago

@ $11.19

Wydano: 13 vas. 2024 @ 17:58

Zwrot: -83.11%

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 23:00):

eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer...

Stats
Dzisiejszy wolumen	161 694
Średni wolumen	379 290
Kapitalizacja rynkowa	6.97M
EPS	$-3.42 ( 2024-03-27 )
Następna data zysków	( $-2.17 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.120
ATR14	$0.0120 (0.63%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-19	Loewy Caroline M	Buy	2 000	Stock Option (Right to Buy)
2024-02-19	Bhatt Elizabeth	Buy	2 000	Stock Option (Right to Buy)
2024-02-19	Ehrlich Christopher B	Buy	2 000	Stock Option (Right to Buy)
2024-02-19	Klencke Barbara	Buy	2 000	Stock Option (Right to Buy)
2024-02-19	Harrington-smith Kristen	Buy	2 000	Stock Option (Right to Buy)

INSIDER POWER
45.06
Last 95 transactions
Buy: 5 541 401 \| Sell: 1 016 887

Wolumen Korelacja

Długi: -0.09 (neutral)

Krótki: -0.54 (weak negative)

Signal:(48.371) Neutral

eFFECTOR Therapeutics, Korelacja

10 Najbardziej pozytywne korelacje
APOP	0.91
FLGT	0.875
PIII	0.875
PRSR	0.871
MAGS	0.871
SOFIW	0.867
CMLF	0.867
LPTX	0.864
AGCUU	0.863
WKSP	0.863

10 Najbardziej negatywne korelacje
ULTA	-0.855
IEP	-0.845
TNDM	-0.833
IART	-0.83
ASO	-0.829
CDAK	-0.828
IQ	-0.827
PAYS	-0.827
SBNYP	-0.817
PHCF	-0.815

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

eFFECTOR Therapeutics, Korelacja - Waluta/Towar

-0.04
( neutral )

0.15
( neutral )

0.00
( neutral )

0.09
( neutral )

0.00
( neutral )

-0.16
( neutral )

eFFECTOR Therapeutics, Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$-111 000 (0.00 %)
EPS:	$-16.37

FY	2023
Przychody:	$0
Zysk brutto:	$-111 000 (0.00 %)
EPS:	$-16.37

FY	2022
Przychody:	$3.55M
Zysk brutto:	$3.50M (98.51 %)
EPS:	$-7.85

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$1.050

Financial Reports:

No articles found.

eFFECTOR Therapeutics,

eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. The company is also developing Zotatifin, a small molecule designed to inhibit eukaryotic initiation factor 4A (eIF4E), which is in phase 2clinical trial to treat patients with solid tumors. It has a collaboration agreement with Pfizer Inc. to develop inhibitors of eIF4E. eFFECTOR Therapeutics, Inc. was founded in 2012 and is headquartered in Solana Beach, California.